我国医院疾病资源库建设现状分析与对策研究  

Status Quo Analysis of Human Clinical Biobank in China and Countermeasure Study

作　　者：倪明宇[1] 李海燕[1] 王彭 王晓民 

机构地区：[1]首都医科大学科技处,北京100069 [2]北京脑重大疾病研究院

出　　处：《中华医学科研管理杂志》2016年第2期88-91,共4页Chinese Journal of Medical Science Research Management

基　　金：北京市科学技术委员会资助项目（D131100005313002）;首都医科大学校长研究基金（14GLY04）

摘　　要：疾病资源库是生物医学研究的重要资源平台，对人类疾病的临床诊疗基础研究起到了巨大的推动作用。在我国，疾病资源库的建设主体是具有生物资源优势的大型综合性医院和专科医院等。这种建库模式相对独立、运转灵活，但同时也存在资源规模不大、存在重复建设、分散、缺乏统一管理的问题。本文重在探讨综合性医院疾病资源库标准化建设机制，推动医院的疾病资源战略平台建设，促进医学发展。Biobank is an important resource for biomedical research, which plays a tremendous role in basic research of clinical diagnosis and treatment of human diseases. In China, the biobank for major diseases was built mainly by large general hospitals which have capacity to access and store large amount of human samples. Such model of repository building is relatively independent, and flexible in operation, but it also has several defects, such as insufficient resources, duplication even in the same hospital, dispersion, and lack of effective and standardized management. This article focuses on the strategy of the standardization of the repository building in large general hospitals, aiming to promote the clinical research platform building in hospital and invigorate medical development.

关 键 词：疾病资源库 精确医学 综合性医院 标准化 

分 类 号：R197.323[医药卫生—卫生事业管理]